Back to catalog
GLP-1 Astral research vial

GLP-1

NNC 0113-0217 · NN9535

A 31-amino-acid acylated analog of GLP-1(7–37), modified for DPP-4 resistance and reversible albumin binding. Supplied as a reference compound for in-vitro GLP-1-receptor pharmacology and incretin-signaling research.

Mass

  • 10 mg$47.99In stock

From $47.99Purity 99.664%Third-party tested— View COA

View purchase options

Specifications

GLP-1 — Specifications
CAS number910463-68-2
Molecular formulaC187H291N45O59
Molecular weight4113.6 g/mol
FormLyophilized powder
Purity (latest released COA)99.664% · AST-SM10-001
Net quantity10 mg / vial

Handling & storage

GLP-1 — Handling & storage
GuidanceStore lyophilized powder at −20 °C, protected from light. After reconstitution with bacteriostatic water, store at 2–8 °C and use within 30 days. Every vial ships with a batch-specific Certificate of Analysis.
For laboratory research use only. Not a drug, food, cosmetic or supplement. Not for human or veterinary consumption, diagnosis, or treatment.

Documentation

Certificates of Analysis

Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.

Current released record

AST-SM10-001

Dosage
10 mg
Purity
99.664%
Laboratory
Janoshik
Analyzed
2026-06-15
Open source PDF

View the compound COA record →